Modest treatment effects and high program attrition: The impact of interdisciplinary, individualized care for

Jillian Ls Avis1, Kathryn A Ambler2, Mary M Jetha2

  • 1Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta;

Insights

An individualized, interdisciplinary weight management program stabilized weight in children with obesity. Further strategies are needed to reduce program attrition and improve long-term success for pediatric weight management.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Clinical Nutrition

Background:

  • Urgent need for effective weight management interventions in pediatric obesity.
  • Real-world clinical settings require proven strategies for childhood obesity.
  • Improving health outcomes for children with obesity is a key public health priority.

Purpose of the Study:

  • Evaluate individualized, interdisciplinary care for pediatric obesity.
  • Assess the link between clinical interactions and weight status changes.
  • Document program attrition rates in a pediatric weight management clinic.

Main Methods:

  • Retrospective review of clinical and administrative data (2008-2012).
  • Included children aged 5-18 years with BMI ≥85th percentile.
  • Analyzed demographic, anthropometric, and attendance data at 3, 7, and 11 months.

Main Results:

  • Weight stabilization observed at 3 and 7 months for participants with available data.
  • A trend towards decreased BMI z-score at 11 months (P=0.06).
  • Significant program attrition observed, increasing over time (73% at 11 months).

Conclusions:

  • Individualized, interdisciplinary care promotes weight stabilization and modest reduction in pediatric obesity.
  • Strategies to minimize program attrition are crucial for optimizing family engagement and treatment success.
  • Further research needed to enhance long-term adherence and outcomes in pediatric weight management programs.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
738